PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 38 filers reported holding PARATEK PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $93,403 | +96.0% | 36,773 | +44.3% | 0.00% | – |
| Q4 2022 | $47,664 | -76.2% | 25,489 | -67.2% | 0.00% | – |
| Q3 2022 | $200,000 | +13.0% | 77,817 | -15.4% | 0.00% | – |
| Q2 2022 | $177,000 | -77.1% | 91,948 | -64.6% | 0.00% | – |
| Q1 2022 | $772,000 | -32.4% | 259,942 | +2.2% | 0.00% | – |
| Q4 2021 | $1,142,000 | -13.7% | 254,313 | -6.7% | 0.00% | – |
| Q3 2021 | $1,324,000 | -23.8% | 272,439 | +7.0% | 0.00% | – |
| Q2 2021 | $1,737,000 | +0.6% | 254,625 | +4.2% | 0.00% | – |
| Q1 2021 | $1,726,000 | +11.4% | 244,359 | -1.3% | 0.00% | – |
| Q4 2020 | $1,549,000 | +83.1% | 247,579 | +58.3% | 0.00% | – |
| Q3 2020 | $846,000 | -28.3% | 156,421 | -30.8% | 0.00% | – |
| Q2 2020 | $1,180,000 | +73.3% | 226,154 | +4.6% | 0.00% | – |
| Q1 2020 | $681,000 | -50.5% | 216,310 | -36.6% | 0.00% | – |
| Q4 2019 | $1,376,000 | +140.6% | 341,322 | +157.5% | 0.00% | – |
| Q3 2019 | $572,000 | +262.0% | 132,567 | +233.7% | 0.00% | – |
| Q2 2019 | $158,000 | -56.0% | 39,723 | -40.7% | 0.00% | – |
| Q1 2019 | $359,000 | -14.7% | 66,979 | -18.5% | 0.00% | – |
| Q4 2018 | $421,000 | +10.5% | 82,171 | +109.4% | 0.00% | – |
| Q3 2018 | $381,000 | -77.3% | 39,241 | -76.1% | 0.00% | – |
| Q2 2018 | $1,675,000 | +154.2% | 164,178 | +224.0% | 0.00% | – |
| Q1 2018 | $659,000 | -22.2% | 50,673 | +7.1% | 0.00% | – |
| Q4 2017 | $847,000 | -83.2% | 47,328 | -76.4% | 0.00% | -100.0% |
| Q3 2017 | $5,030,000 | +58.4% | 200,371 | +52.1% | 0.00% | 0.0% |
| Q2 2017 | $3,175,000 | +76.4% | 131,723 | +40.9% | 0.00% | – |
| Q1 2017 | $1,800,000 | +46.8% | 93,501 | +17.5% | 0.00% | – |
| Q4 2016 | $1,226,000 | -14.6% | 79,595 | -27.8% | 0.00% | – |
| Q3 2016 | $1,435,000 | +13.0% | 110,227 | +20.7% | 0.00% | – |
| Q2 2016 | $1,270,000 | +247.9% | 91,334 | +682.0% | 0.00% | – |
| Q1 2015 | $365,000 | – | 11,679 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 2,600,410 | $10,480,000 | 3.34% |
| Roumell Asset Management, LLC | 340,323 | $1,372,000 | 3.14% |
| Abingworth LLP | 1,041,131 | $4,185,000 | 2.02% |
| ICM ASSET MANAGEMENT INC/WA | 448,315 | $1,807,000 | 1.48% |
| Trellus Management Company, LLC | 147,055 | $593,000 | 0.99% |
| Prosight Management, LP | 450,000 | $1,814,000 | 0.80% |
| ARMISTICE CAPITAL, LLC | 2,268,000 | $9,140,000 | 0.53% |
| Arbiter Partners Capital Management LLC | 848,069 | $3,418,000 | 0.50% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 966,493 | $3,895,000 | 0.30% |
| GENERAL AMERICAN INVESTORS CO INC | 644,323 | $2,597,000 | 0.24% |